These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 22883000

  • 21. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
    Pastores GM, Elstein D, Hrebícek M, Zimran A.
    Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
    [Abstract] [Full Text] [Related]

  • 22. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
    Aydın OA, Karaosmanoglu HK, Karahasanoglu R, Tahmaz M, Nazlıcan O.
    Braz J Infect Dis; 2013 Aug; 17(6):707-11. PubMed ID: 24076108
    [Abstract] [Full Text] [Related]

  • 23. Stable bone density in HAART-treated individuals with HIV: a meta-analysis.
    Bolland MJ, Wang TK, Grey A, Gamble GD, Reid IR.
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2721-31. PubMed ID: 21715534
    [Abstract] [Full Text] [Related]

  • 24. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis.
    Patel R, Blake GM, Fogelman I.
    Calcif Tissue Int; 2007 Feb; 80(2):89-96. PubMed ID: 17308990
    [Abstract] [Full Text] [Related]

  • 25. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.
    AIDS; 2007 Nov 30; 21(18):2473-82. PubMed ID: 18025884
    [Abstract] [Full Text] [Related]

  • 26. Should COPD patients be routinely evaluated for bone mineral density?
    Karadag F, Cildag O, Yurekli Y, Gurgey O.
    J Bone Miner Metab; 2003 Nov 30; 21(4):242-6. PubMed ID: 12811630
    [Abstract] [Full Text] [Related]

  • 27. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
    Planas J, Trilla E, Raventós C, Cecchini L, Orsola A, Salvador C, Placer J, Encabo G, Morote J.
    BJU Int; 2009 Dec 30; 104(11):1637-40. PubMed ID: 19549260
    [Abstract] [Full Text] [Related]

  • 28. Body habitus changes, metabolic abnormalities, osteopenia and cardiovascular risk in patients treated for human immunodeficiency virus infection.
    Cirelli A, Cirelli G, Balsamo G, Masciangelo R, Stasolla A, Marini M.
    Ann Ital Med Int; 2003 Dec 30; 18(4):238-45. PubMed ID: 14971712
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
    Abeş M, Sarihan H, Madenci E.
    J Pediatr Surg; 2003 Feb 30; 38(2):230-2. PubMed ID: 12596110
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy.
    Bruder JM, Ma JZ, Basler JW, Welch MD.
    Urology; 2006 Jan 30; 67(1):152-5. PubMed ID: 16413352
    [Abstract] [Full Text] [Related]

  • 31. Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density.
    Khawaji M, Akesson K, Berntorp E.
    Haemophilia; 2009 Jan 30; 15(1):261-6. PubMed ID: 19149852
    [Abstract] [Full Text] [Related]

  • 32. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, Doria AS, Stephens D, Gilday D, Silverman ED.
    Arthritis Rheum; 2007 Jun 30; 56(6):1966-73. PubMed ID: 17530722
    [Abstract] [Full Text] [Related]

  • 33. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register.
    Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK.
    Arthritis Rheum; 2000 Mar 30; 43(3):522-30. PubMed ID: 10728744
    [Abstract] [Full Text] [Related]

  • 34. Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children.
    Mora S, Zamproni I, Beccio S, Bianchi R, Giacomet V, Viganò A.
    J Clin Endocrinol Metab; 2004 Jan 30; 89(1):24-8. PubMed ID: 14715822
    [Abstract] [Full Text] [Related]

  • 35. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
    Terzi T, Terzi M, Tander B, Cantürk F, Onar M.
    J Clin Neurosci; 2010 Oct 30; 17(10):1260-4. PubMed ID: 20619660
    [Abstract] [Full Text] [Related]

  • 36. Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
    Wadhwa VK, Weston R, Mistry R, Parr NJ.
    BJU Int; 2009 Sep 30; 104(6):800-5. PubMed ID: 19338564
    [Abstract] [Full Text] [Related]

  • 37. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL, Lai PSM, Tan ATB, Ponnampalavanar S.
    Osteoporos Int; 2018 Mar 30; 29(3):595-613. PubMed ID: 29159533
    [Abstract] [Full Text] [Related]

  • 38. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
    Assoumou L, Katlama C, Viard JP, Bentata M, Simon A, Roux C, Kolta S, Costagliola D, Rozenberg S, ANRS Osteovir study group.
    AIDS; 2013 Sep 24; 27(15):2425-30. PubMed ID: 24029735
    [Abstract] [Full Text] [Related]

  • 39. Hypovitaminosis D and bone mineral density in human immunodeficiency virus-infected men from India, with or without antiretroviral therapy.
    Paul TV, Asha HS, Thomas N, Seshadri MS, Rupali P, Abraham OC, Pulimood SA, Jose A.
    Endocr Pract; 2010 Sep 24; 16(4):547-53. PubMed ID: 20150027
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the possible risk factors of bone mineral density in subjects with ulcerative colitis and healthy subjects.
    Kaya G, Koçak E, Akbal E, Taş A, Köklü S.
    South Med J; 2011 Nov 24; 104(11):747-51. PubMed ID: 22024784
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.